Buzone Conc. (Canada)

Manufacturer: Vétoquinol

Phenylbutazone Powder

Veterinary Use Only

Flavored

DIN 02105748

Warning

Do not use this product in food producing animals including horses that are to be slaughtered for use as food. Keep out of reach of children.

Active Ingredient	Per G
Phenylbutazone	266.66 mg

Buzone Conc. Indications

As an aid in the treatment of arthritis, myositis and rheumatism in horses.

Dosage: Horses

Administer orally 1 to 2 g of phenylbutazone per 227 kg of body weight, daily, in at least 2 divided doses. Daily dosage should not exceed 4 g. As symptoms regress, reduce dosage to a level able to control the condition. In some cases treatment should be given only while symptoms are evident with no need for continuous medication.

Note

1 level tablespoon of powder contains approximately 3 g of phenylbutazone.

Buzone Conc. Caution

If no significant clinical improvement is noted in 5 days, the diagnosis and treatment should be re-evaluated. Discontinue medication if signs of gastrointestinal upset or blood dyscrasia appear.

Contraindications

This treatment is contraindicated in horses with cardiac, renal or hepatic insufficiency and in cases with signs or history of anemia. The use of this product is contraindicated in horses with preexisting gastrointestinal ulcers.

Storage Conditions

Store between 15 and 25 °C. Protect from moisture.

Made in Canada

Vétoquinol N.-A. Inc., 2000, chemin Georges, Lavaltrie, QC, Canada J5T 3S5

Net	Code
225 g	20090	656045D

Nac No.

12341034